Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti

被引:33
|
作者
Mathieu, E
Lammie, PJ
Radday, J
Beach, MJ
Streit, T
Wendt, J
Addiss, DG
机构
[1] Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA
[2] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA
[3] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA
来源
关键词
D O I
10.1179/000349804X3135
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In October 2000, to interrupt transmission of Wuchereria bancrofti, an intense health-education campaign followed by a mass drug administration (MDA) with diethylcarbamazine and albendazole was undertaken in Leogane, Haiti. Three months after the MDA, which was the first in the study area, a knowledge-attitude-practice (KAP) survey, with a cluster-sample design and probability sampling, was undertaken, to determine the existing knowledge of the local residents, their attitudes toward the MDA, and the possible reasons for non-compliance. Questionnaire-based interviews were used to explore the KAP of 304 subjects (one randomly chosen resident aged > 14 years from each selected household) in 33 communities. Most (93%) of the interviewees were aware of filariasis and 72% knew at least one clinical sign of the disease. Awareness of the MDA was high (91%). The most frequently mentioned sources of information were other people (56%) and radio announcements (33%). More than 80% of the respondents encouraged other people to take the drugs distributed in the MDA and 63% had been treated. The primary reasons given for failing to take the drugs were absenteeism during the distribution (17%), use of contraceptive drugs (12%) and pregnancy (11 %). In a multivariate analysis, being male [odds ratio (OR) =3.3; 95% confidence interval (CI)=1.5-7.4], knowing that a mosquito transmits the disease (OR=2.6; CI=1.2-5.4), and having learned about the MDA through posters and banners (OR= 2.9; CI =1.2-7.5) were found to be positively associated with taking the drugs. Information from such post-treatment surveys should be useful in developing better health communication for subsequent MDA.
引用
收藏
页码:703 / 714
页数:12
相关论文
共 50 条
  • [31] Factors influencing compliance to mass drug administration for control of lymphatic filariasis in Tanzania
    Meyrowitsch, D.
    Kisoka, W.
    Mushi, D.
    Malecela, M.
    Simonsen, P.
    Tersboel, B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 55 - 55
  • [32] A qualitative study on the adverse reactions of mass treatment for lymphatic filariasis in Orissa,India
    Babu BV
    Asian Pacific Journal of Tropical Medicine, 2010, 3 (01) : 55 - 58
  • [33] A qualitative study on the adverse reactions of mass treatment for lymphatic filariasis in Orissa, India
    Babu, B., V
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2010, 3 (01) : 55 - 58
  • [34] AN EPIDEMIOLOGIC SURVEY AND RISK FACTORS ASSOCIATED WITH LYMPHATIC FILARIASIS IN THE MIDDLE BELT OF GHANA
    Atibilla, Dorcas
    Dosoo, David K.
    Ana-aro, Joseph
    Tawfiq, Yussif
    Ankrah, Love
    Jakpa, Gabriel
    Kayan, Kingsley
    Owusu-Agyei, Seth
    Asante, Kwaku Poku
    Oppong, Felix B.
    Wilson, Michael D.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 49 - 49
  • [35] Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa
    Lemin, Morgan E.
    Restrepo, Angela Cadavid
    Mayfield, Helen J.
    Lau, Colleen L.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (10)
  • [36] SAFETY AND EFFICACY OF CO-ADMINISTERED DIETHYLCARBAMZINE, ALBENDAZOLE AND IVERMECTION DURING MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS IN HAITI
    Dubray, Christine
    Sircar, Anita
    de Rochars, Madsen
    Bogus, Joshua
    Direny, Abdel
    Ernest, Jean
    Fayette, Carl
    O'Brian, Katiuscia
    Pavilus, Guy
    Sabin, Daniel
    Wiegand, Ryan
    Weil, Gary
    Lemoine, Jean
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 1 - 1
  • [37] Multiplex Bead Assay for Serum Samples from Children in Haiti Enrolled in a Drug Study for the Treatment of Lymphatic Filariasis
    Moss, Delynn M.
    Priest, Jeffrey W.
    Boyd, Alexis
    Weinkopff, Tiffany
    Kucerova, Zuzana
    Beach, Michael J.
    Lammie, Patrick J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 85 (02): : 229 - 237
  • [38] A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
    Krentel, Alison
    Fischer, Peter U.
    Weil, Gary J.
    PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (11):
  • [39] SOCIO-ECONOMIC AND BEHAVIORAL FACTORS THAT INFLUENCE COMPLIANCE WITH MASS TREATMENT IN THE NATIONAL PROGRAMME FOR ELIMINATION OF LYMPHATIC FILARIASIS IN KENYA
    Njomo, Doris W.
    Nyamongo, Mary A.
    Njenfa, Sammy M.
    Magambo, Japheth K.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 67 - 67
  • [40] Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria
    Pam, Dung D.
    de Souza, Dziedzom K.
    D'Souza, Susan
    Opoku, Millicent
    Sanda, Safiya
    Nazaradden, Ibrahim
    Anagbogu, Ifeoma N.
    Okoronkwo, Chukwu
    Davies, Emmanuel
    Elhassan, Elisabeth
    Molyneux, David H.
    Bockarie, Moses J.
    Koudou, Benjamin G.
    PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (10):